Fluocortolone
Chemical compound
- C05AA08 (WHO) D07AC05 (WHO) H02AB03 (WHO)
- (1S,2R,8S,10S,11S,13R,14S,15S,17S)-8-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one
- 152-97-6
N
- 9053
- DB08971 N
- 8701
Y
- 65VXC1MH0J
- D04218 Y
- ChEMBL251634 Y
- DTXSID00861835
- Interactive image
- O=C\1\C=C/[C@]4(/C(=C/1)[C@@H](F)C[C@@H]2[C@@H]4[C@@H](O)C[C@@]3([C@@H](C(=O)CO)[C@@H](C[C@@H]23)C)C)C
InChI
- InChI=1S/C22H29FO4/c1-11-6-14-13-8-16(23)15-7-12(25)4-5-21(15,2)20(13)17(26)9-22(14,3)19(11)18(27)10-24/h4-5,7,11,13-14,16-17,19-20,24,26H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19-,20-,21+,22+/m1/s1Y
- Key:GAKMQHDJQHZUTJ-ULHLPKEOSA-NY
N
Y (what is this?) (verify)Fluocortolone is a glucocorticoid[1] used in the treatment of several conditions, including hemorrhoids.
It is similar to fluocortin, but with one less keto group.
See also
References
- ^ Munro DD, Wilson HT, Rhodes EL (November 1967). "Comparison of betamethasone 17-valerate ointment with fluocortolone and fluocortolone caproate ointment". British Medical Journal. 4 (5574): 275–6. doi:10.1136/bmj.4.5574.275. PMC 1748932. PMID 6054003.
- v
- t
- e
| Natural | |
|---|---|
| Synthetic |
|
- Antagonists: Aglepristone
- Ketoconazole
- Mifepristone
- Ulipristal acetate
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- Glucocorticoid receptor modulators
- Mineralocorticoids and antimineralocorticoids
- List of corticosteroids
 | This hormonal preparation article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
 | This dermatologic drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
